Sam, I., Benhamouda, N., Biard, L., Meda, L. D., Desseaux, K., Baroudjan, B., . . . Tartour, E. (2025). Soluble CD27 differentially predicts resistance to anti-PD1 alone but not with anti-CTLA-4 in melanoma. EMBO Molecular Medicine, 17(5), 909-922. https://doi.org/10.1038/s44321-025-00203-9
Chicago Style (17th ed.) CitationSam, Ikuan, et al. "Soluble CD27 Differentially Predicts Resistance to Anti-PD1 Alone but Not with Anti-CTLA-4 in Melanoma." EMBO Molecular Medicine 17, no. 5 (2025): 909-922. https://doi.org/10.1038/s44321-025-00203-9.
MLA (9th ed.) CitationSam, Ikuan, et al. "Soluble CD27 Differentially Predicts Resistance to Anti-PD1 Alone but Not with Anti-CTLA-4 in Melanoma." EMBO Molecular Medicine, vol. 17, no. 5, 2025, pp. 909-922, https://doi.org/10.1038/s44321-025-00203-9.